Correction: CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy (Proceedings of the National Academy of Sciences of the United States of America (2010) 107 (14484–14489) DOI: 10.1073/pnas.1008256107);CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 32, 2010, Pages 14484-14489

  De Nigris, Filomena ^a   Crudele, Valeria ^a   Giovane, Alfonso ^a   Casamassimi, Amelia ^a   Giordano, Antonio ^b,c   Garban, Hermes J ^d   Cacciatore, Francesco ^e   Pentimalli, Francesca ^b   Marquez Garban, Diana C ^d   Petrillo, Antonella ^f   Cito, Letizia ^b   Sommese, Linda ^a   Fiore, Andrea ^a   Petrillo, Mario ^f   Siani, Alfredo ^f   Barbieri, Antonio ^f   Arra, Claudio ^f   Rengo, Franco ^e   Hayashi, Toshio ^g   Al Omran, Mohammed ^h   Ignarro, Louis J ^d,h   Napoli, Claudio ^a,h   more..

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Temple University   (United States)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f NATIONAL CANCER INSTITUTE   (Italy)

^g NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Cancer; Metastasis; Oncogene

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; TRANSCRIPTION FACTOR YY1; VASCULOTROPIN; VASCULOTROPIN B; HIF1A PROTEIN, RAT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PEPTIDE; T22 PEPTIDE; TRANSCRIPTION FACTOR; YY1 PROTEIN, HUMAN;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CANCER TRANSPLANTATION; DRUG ANTAGONISM; GENETICS; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; TUMOR CELL LINE; VASCULARIZATION; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; RATS; RECEPTOR CROSS-TALK; RECEPTORS, CXCR4; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTORS; YY1 TRANSCRIPTION FACTOR;

EID: 77956282766     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1902206116     Document Type: Erratum

References (26)

1. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
2. Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3:401-410.
3. Grothey A, Galanis E (2009) Targeting angiogenesis: Progress with anti-VEGF treatment with large molecules. Nat Rev Clin Oncol 6:507-518.
4. Gordon S, Akopyan G, Garban H, Bonavida B (2006) Transcription factor YY1: Structure, function, and therapeutic implications in cancer biology. Oncogene 25:1125-1142.
5. Garbán HJ, Bonavida BJ (2001) Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: A pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells. J Immunol 167:75-81.
6. Baritaki S, et al. (2008) Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cells. J Immunol 180:6199-6210.
7. Sui G, et al. (2004) Yin Yang 1 is a negative regulator of p53. Cell 117:859-872.
8. de Nigris F, et al. (2008) Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis. Cancer Res 68:1797-1808.
9. Wong D, Korz W (2008) Translating an antagonist of chemokine receptor CXCR4: From bench to bedside. Clin Cancer Res 14:7975-7980.
10. de Nigris F, et al. (2007) Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells. Oncogene 26:382-394.
11. Zlotnik A (2008) New insights on the role of CXCR4 in cancer metastasis. J Pathol 215:211-213.
12. Hotte SJ, et al. (2008) A phase 1 study of mapatumumab (fully human monoclonal antibody to TRAIL-R1) in patients with advanced solid malignancies. Clin Cancer Res 14:3450-3455.
13. Staton CA, Reed MW, Brown NJ (2009) A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Pathol 90:195-221.
14. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669-676.
15. Liang Z, et al. (2007) CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem Biophys Res Commun 359:716-722.
16. Kerbel RS (2008) Tumor angiogenesis. N Engl J Med 358:2039-2049.
17. Ellis LM, Hicklin DJ (2008) VEGF-targeted therapy: Mechanisms of anti-tumour activity. Nat Rev Cancer 8:579-591.
18. Chen HX, Cleck JN (2009) Antiangiogenic clinical strategies: Adverse effect of anticancer agents that target the VEGF pathway. Nat Rev Clin Oncol 6:465-477.
19. Crawford Y, Ferrara N (2009) Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies. Trends Pharmacol Sci 30:624-630.
20. de Nigris F, et al. (2006) Expression of transcription factor Yin Yang 1 in human osteosarcomas. Eur J Cancer 42:2420-2424.
21. Harper SJ, Bates DO (2008) VEGF-A splicing: The key to anti-angiogenic therapeutics? Nat Rev Cancer 8:880-887.
22. Petrella BL, Brinckerhoff CE (2009) PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma. Cancer Biol Ther 8:1389-1401.
23. Austen M, Luscher B, Luscher-Firzlaff JM (1997) Charaterization of transcription regulator YY1. J Biol Chem 272:1709-1717.
24. Rizkallah R, Hurt MM (2009) Regulation of the transcription factor YY1 in mitosis through phosphorylation of its DNA-binding domain. Mol Biol Cell 20:4766-4776.
25. Huerta-Yepez S, et al. (2009) Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1. Nitric Oxide 20:39-52.
26. Balestrieri ML, Napoli C (2007) Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors. Eur J Cancer 43:1242-1250.